BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32701261)

  • 1. Nanolipoprotein Particles as a Delivery Platform for Fab Based Therapeutics.
    Darwish M; Shatz W; Leonard B; Loyet K; Barrett K; Wong JL; Li H; Abraham R; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Blanchette C
    Bioconjug Chem; 2020 Aug; 31(8):1995-2007. PubMed ID: 32701261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanolipoprotein particles for co-delivery of cystine-knot peptides and Fab-based therapeutics.
    Darwish M; Gao X; Shatz W; Li H; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Hannoush RN; Blanchette C
    Nanoscale Adv; 2021 Jun; 3(13):3929-3941. PubMed ID: 36133017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake.
    Gilmore SF; Blanchette CD; Scharadin TM; Hura GL; Rasley A; Corzett M; Pan CX; Fischer NO; Henderson PT
    ACS Appl Mater Interfaces; 2016 Aug; 8(32):20549-57. PubMed ID: 27411034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform.
    Fischer NO; Weilhammer DR; Dunkle A; Thomas C; Hwang M; Corzett M; Lychak C; Mayer W; Urbin S; Collette N; Chiun Chang J; Loots GG; Rasley A; Blanchette CD
    PLoS One; 2014; 9(3):e93342. PubMed ID: 24675794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.
    Blanchette CD; Segelke BW; Fischer N; Corzett MH; Kuhn EA; Cappuccio JA; Benner WH; Coleman MA; Chromy BA; Bench G; Hoeprich PD; Sulchek TA
    Int J Mol Sci; 2009 Jul; 10(7):2958-2971. PubMed ID: 19742178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
    Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
    ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III.
    Fischer NO; Blanchette CD; Segelke BW; Corzett M; Chromy BA; Kuhn EA; Bench G; Hoeprich PD
    PLoS One; 2010 Jul; 5(7):e11643. PubMed ID: 20657844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles.
    Blanchette CD; Cappuccio JA; Kuhn EA; Segelke BW; Benner WH; Chromy BA; Coleman MA; Bench G; Hoeprich PD; Sulchek TA
    Biochim Biophys Acta; 2009 Mar; 1788(3):724-31. PubMed ID: 19109924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and Protein Transfer between Nanolipoprotein Particles and Supported Lipid Bilayers.
    Dang AT; He W; Ivey DB; Coleman MA; Kuhl TL
    Langmuir; 2019 Sep; 35(37):12071-12078. PubMed ID: 31442053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nanoparticle Platform To Evaluate Bioconjugation and Receptor-Mediated Cell Uptake Using Cross-Linked Polyion Complex Micelles Bearing Antibody Fragments.
    Florinas S; Liu M; Fleming R; Van Vlerken-Ysla L; Ayriss J; Gilbreth R; Dimasi N; Gao C; Wu H; Xu ZQ; Chen S; Dirisala A; Kataoka K; Cabral H; Christie RJ
    Biomacromolecules; 2016 May; 17(5):1818-33. PubMed ID: 27007881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA.
    He W; Evans AC; Rasley A; Bourguet F; Peters S; Kamrud KI; Wang N; Hubby B; Felderman M; Gouvis H; Coleman MA; Fischer NO
    Nanomedicine; 2020 Feb; 24():102154. PubMed ID: 31982617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different apolipoproteins impact nanolipoprotein particle formation.
    Chromy BA; Arroyo E; Blanchette CD; Bench G; Benner H; Cappuccio JA; Coleman MA; Henderson PT; Hinz AK; Kuhn EA; Pesavento JB; Segelke BW; Sulchek TA; Tarasow T; Walsworth VL; Hoeprich PD
    J Am Chem Soc; 2007 Nov; 129(46):14348-54. PubMed ID: 17963384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W; Huang Z; MacKay JA; Grube S; Szoka FC
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles.
    Fischer NO; Blanchette CD; Chromy BA; Kuhn EA; Segelke BW; Corzett M; Bench G; Mason PW; Hoeprich PD
    Bioconjug Chem; 2009 Mar; 20(3):460-5. PubMed ID: 19239247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of lipid phase behavior and protein conformational changes in nanolipoprotein particles upon entrapment in sol-gel-derived silica.
    Zeno WF; Hilt S; Aravagiri KK; Risbud SH; Voss JC; Parikh AN; Longo ML
    Langmuir; 2014 Aug; 30(32):9780-8. PubMed ID: 25062385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative binding of disulfide-bridged PEG-Fabs.
    Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
    Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes.
    Shahinian S; Silvius JR
    Biochim Biophys Acta; 1995 Nov; 1239(2):157-67. PubMed ID: 7488620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of highly reactive cysteine residues at less exposed positions in the Fab constant region for site-specific conjugation.
    Shiraishi Y; Muramoto T; Nagatomo K; Shinmi D; Honma E; Masuda K; Yamasaki M
    Bioconjug Chem; 2015 Jun; 26(6):1032-40. PubMed ID: 25978737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry.
    He W; Luo J; Bourguet F; Xing L; Yi SK; Gao T; Blanchette C; Henderson PT; Kuhn E; Malfatti M; Murphy WJ; Cheng RH; Lam KS; Coleman MA
    Protein Sci; 2013 Aug; 22(8):1078-86. PubMed ID: 23754445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations.
    Blanchette CD; Law R; Benner WH; Pesavento JB; Cappuccio JA; Walsworth V; Kuhn EA; Corzett M; Chromy BA; Segelke BW; Coleman MA; Bench G; Hoeprich PD; Sulchek TA
    J Lipid Res; 2008 Jul; 49(7):1420-30. PubMed ID: 18403317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.